Nano-X Imaging (NNOX) Change in Receivables (2022 - 2026)
Nano-X Imaging (NNOX) posted quarterly Change in Receivables of -$196000.0 for Q1 2026, down 336.14% year-on-year from $83000.0 in Q1 2025, and down 884.0% on a QoQ basis from $25000.0 in Q4 2025.
Nano-X Imaging (NNOX) Change in Receivables (2022 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Change in Receivables for 5 consecutive years, with -$196000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Receivables fell 336.14% year-over-year to -$196000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$386000.0 (down 206.63% YoY) and the FY2025 annual result came in at -$107000.0, down 133.33% from the prior year.
- Change in Receivables fell to -$196000.0 in Q1 2026 per NNOX's latest filing, from $25000.0 in the prior quarter.
- Over the last five years, Change in Receivables for NNOX reached as high as $693000.0 in Q4 2023 and fell as low as -$331000.0 in Q1 2023.
- A 5-year average of $26529.4 and a median of -$4000.0 in 2022 frame the typical range for Change in Receivables.
- The largest YoY upside for Change in Receivables was 17425.0% in 2023 against a maximum downside of 748.72% in 2023.
- Year by year, Change in Receivables stood at -$4000.0 in 2022, then surged by 17425.0% to $693000.0 in 2023, then plunged by 52.53% to $329000.0 in 2024, then tumbled by 92.4% to $25000.0 in 2025, then plunged by 884.0% to -$196000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$196000.0, $25000.0, and -$57000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -196,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -196,000.00 |
| Mar 31, 2026 | -196,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | -57,000.00 |
| Sep 30, 2025 | -57,000.00 |
| Jun 30, 2025 | -158,000.00 |
| Jun 30, 2025 | -158,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -66,000.00 |
| Jun 30, 2024 | -66,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 693,000.00 |
| Dec 31, 2023 | 693,000.00 |